Pallas Capital Advisors LLC Invests $1.80 Million in Globe Life Inc. $GL

Pallas Capital Advisors LLC acquired a new stake in Globe Life Inc. (NYSE:GL) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 10,078 shares of the company’s stock, valued at approximately $1,801,000.

A number of other large investors have also recently bought and sold shares of the business. CYBER HORNET ETFs LLC acquired a new position in Globe Life during the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Globe Life in the fourth quarter worth $30,000. MUFG Securities EMEA plc bought a new stake in shares of Globe Life during the 2nd quarter worth $31,000. Torren Management LLC bought a new stake in shares of Globe Life during the 4th quarter worth $37,000. Finally, AdvisorNet Financial Inc grew its stake in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after buying an additional 92 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Cheryl Alston sold 8,258 shares of Globe Life stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the sale, the director directly owned 16,621 shares of the company’s stock, valued at $2,979,148.04. The trade was a 33.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of the business’s stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total value of $4,580,577.00. Following the transaction, the chief financial officer owned 50,568 shares of the company’s stock, valued at $9,030,433.44. The trade was a 33.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 179,844 shares of company stock valued at $31,616,279 over the last 90 days. Corporate insiders own 2.11% of the company’s stock.

Globe Life Stock Down 0.6%

Shares of NYSE GL opened at $180.00 on Tuesday. The stock has a market cap of $13.83 billion, a PE ratio of 11.95 and a beta of 0.48. The business has a fifty day moving average of $177.61 and a two-hundred day moving average of $157.71. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the business posted $3.05 EPS. The business’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities research analysts expect that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life announced that its Board of Directors has approved a stock repurchase program on Monday, August 10th that authorizes the company to buyback $2.50 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 17.7% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its stock is undervalued.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be issued a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is currently 8.76%.

Analyst Ratings Changes

Several brokerages have recently issued reports on GL. Piper Sandler raised their price target on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. TD Cowen boosted their price objective on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Truist Financial increased their target price on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. JPMorgan Chase & Co. raised their target price on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Finally, Jefferies Financial Group lifted their price target on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.